SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-13-002698
Filing Date
2013-03-14
Accepted
2013-03-14 07:21:40
Documents
13
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2213560z10-k.htm 10-K 1171919
2 EX-10.6.6 a2213560zex-10_66.htm EX-10.6.6 60376
3 EX-23.1 a2213560zex-23_1.htm EX-23.1 3484
4 EX-31.1 a2213560zex-31_1.htm EX-31.1 7933
5 EX-31.2 a2213560zex-31_2.htm EX-31.2 7979
6 EX-32.1 a2213560zex-32_1.htm EX-32.1 4907
13 G216131.JPG g216131.jpg GRAPHIC 82398
  Complete submission text file 0001047469-13-002698.txt   7076044

Data Files

Seq Description Document Type Size
7 EX-101.INS snta-20121231.xml EX-101.INS 800347
8 EX-101.SCH snta-20121231.xsd EX-101.SCH 63181
9 EX-101.CAL snta-20121231_cal.xml EX-101.CAL 77702
10 EX-101.LAB snta-20121231_lab.xml EX-101.LAB 987430
11 EX-101.PRF snta-20121231_pre.xml EX-101.PRE 465182
12 EX-101.DEF snta-20121231_def.xml EX-101.DEF 247797
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000
Type: 10-K | Act: 34 | File No.: 001-33277 | Film No.: 13689103
SIC: 2834 Pharmaceutical Preparations